Sanofi/GSK Arixtra Adds DVT, Pulmonary Embolism Treatment Indications
This article was originally published in The Pink Sheet Daily
Executive Summary
Expanded indication comes as Sanofi prepares to divest Arixtra to GlaxoSmithKline in connection with its proposed acquisition of Lovenox-maker Aventis.